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Cordyceps belongs to a genus of acormycete fungi and is known to exhibit various
pharmacological effects. The aim of this study was to investigate the effect of Cordyceps
species on the proliferation of vascular smooth muscle cells (VSMC) and their underlying
molecular mechanism. A cell proliferation assay showed that Cordyceps bassiana ethanol
extract (CBEE) significantly inhibited VSMC proliferation. In addition, neointimal
formation was significantly reduced by treatment with CBEE in the carotid artery of
balloon-injured rats. We also investigated the effects of CBEE on the extracellular
signal-regulated kinase (ERK) signal pathway. Western blot analysis revealed increased
ERK 1/2 phosphorylation in VSMCs treated with CBEE. Pretreatment with U0126
completely abrogated CBEE-induced ERK 1/2 phosphorylation. In conclusion, CBEE
exhibited anti-proliferative properties that affected VSMCs through the ERK1/2
MAPK signaling pathway. Our data may elucidate the inhibitory mechanism of this
natural product.
Keywords: Cordyceps, ERK pathway, Inhibitory, MAPK, Mechanism, Natural product,
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Atherosclerosis is a disease characterized by thickening of the inner portion of the
artery walls [1]. One of the main pathological characteristics of this disease is the pro-
liferation of vascular smooth muscle cells (VSMC). Recent studies have demonstrated
a close relationship between restenosis and VSMC proliferation in the intimal layer
due to accumulation of cells and extracellular matrix [2].
Cordyceps belongs to a genus of acormycete fungi that includes about 400 species
[3]. Representative Cordyceps species are C. sinensis and C. militaris, which are have
been used as traditional medicine for various diseases in Asian countries. These exhibit
various pharmacological effects including anti-inflammatory, antioxidative, antidiabetic,
and anticancer properties [4].
Cordycepin inhibits VSMC proliferation [5]. However, its anti-proliferative effects
in VSMC and the underlying mechanisms of the Cordyceps species have yet to be
addressed. We investigated the anti-proliferative activity of Cordyceps species
extracts in VSMC and studied the underlying signal transduction mechanism.
Therefore, our study investigates that the molecular mechanism underlying the© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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light a potential therapeutic intervention for cardiovascular disease.Methods
Materials
Cordyceps bassiana ethanol extract (CBEE), Cordyceps militaris butanol extract
(CMBE), and Cordyceps pruinosa methanol extract (CPME) were extracted using
conventional extraction methods [6]. The signal pathway inhibitors U0126,
SP600125, and SB202190 were purchased from Calbiochem (La Jolla, CA, USA).
Antibodies against ERK, phospho-ERK, JNK, phospho-JNK, p38 MAPK, and
phospho-p38 MAPK were purchased from Cell Signaling Technology (Beverly, MA,
USA). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG was used as
the secondary antibody.Solvent extraction
Solvent extraction was performed as described previously [6, 7]. In brief, Air-dried
Cordyceps (175 g) were powdered and extracted at 70 ~ 80 °C with 80 % ethanol,
methanol and butanol. The extract was filtered, taken to dryness under reduced pres-
sure and concentrated by a rotary vacuum evaporator (EYELA N-1000, Japan). The
lyophilized crude extracts were sequentially fractionated with n-hexane (Hexane), ethyl
acetate (EtOAc) and n-butanol (BuOH). Each extract was dissolved in dimethyl
sulphoxide (DMSO) as a concentration.Cell culture
Rat aortic smooth muscle cells (RaoSMCs) were cultured in DMEM supplemented with
fetal bovine serum (Gibco, Grand Island, NY, USA) in 75 cm2 flasks in a 37 °C incubator
at 5 % CO2.Cell proliferation assays
RaoSMCs were plated in triplicate in 96-well plates at 2 × 103 cells per well. The cells
were starved with 0.1 % FBS for 24 h and then treated with three kinds of Cordyceps
extracts or 10 % serum. After treatment, cell proliferation was measured using a CCK-8
assay kit (Dojindo, Japan). The CCK-8 assay kit was treated with DMEM, and then 100 μl
was added to each well and incubated for 2 h at 37 °C. The absorbance was measured at
450 nm with a spectrometer.Neointima formation assay
Animal experiment conforms to the Animal Care and NIH guidelines were
approved by the local animal care committee. Balloon denudation of the common
carotid artery endothelium was evoked in four-week old 250 g Male Sprague–Dawley rats
(Daihan-Biolink Co., Chungbuk, Korea) as previously reported [5, 8]. All rats were
anaesthetized with Ketamine (10 mg/kg, Yuhan, Seoul, Korea) and Xylazine (5 mg/kg,
Bayer Korea, Seoul, Korea). After exposure of the left carotid artery, a 2F Fogarty
balloon catheter (Edwards Lifesciences, Mississauga, ON) was inserted into the exter-
nal carotid branch to the aortic arch. And then catheter was insufflated to produce
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the same procedure and the exception of the balloon insertion. Vehicle (saline) or 0.05 ml
of CBEE (4 μg/ml) was administered daily via ip. for 3 weeks after the balloon injury.H&E staining
Sprague–Dawley rats were sacrificed 3 weeks after the balloon injury. And their
carotid arteries were harvested and fixed with 4 % paraformaldehyde. Within 24 h
after fixation, each section was embedded in OCT compound (Sakura Finetek USA,
Torrance, CA, USA), snap frozen in liquid nitrogen, and sectioned in thickness
increments of 10-μm carotid artery sections were cut with a microtome and
mounted on slides. Sections were stained with hematoxylin and eosin (H&E) and
evaluated with light microscopy to assess the histological effects. Normal and
neointimal areas were measured using NIH images.Western blotting
The western blot analysis was performed as previously described [9, 10]. Cells were
washed once with PBS and then protein was extracted using a lysis buffer (Biosesang,
Korea) containing 150 mM NaCl, 1 % Triton X-100, 1 % sodium deoxycholate, 0.1 % SDS,
50 mM Tris/HCl (pH 7.5), and 2mM EDTA (pH8.0) with a protease inhibitor
cocktail (GenDEPOT, Barker, TX, USA) and phosphatase inhibitor cocktail (Sigma, St.
Louis, MO, USA). Protein concentrations were determined using a BCA protein
assay kit (Pierce Biotechnology, Rockford, IL, USA). For western blotting, equal
amounts of protein were electrophoresed on 12 % sodium dodecyl sulfate (SDS)–
polyacrylamide gels, transferred to nitrocellulose membranes (BioRad, Hercules,
CA, USA), blocked using TBS-T (TBS-Tween 20; 0.1 % Tween 20) containing 5 %
(w/v) non-fat dried skim milk powder for 1 h at room temperature, and incubated with
monoclonal primary antibodies (1:1000) in a blocking buffer overnight at 4 °C [8, 11]. The
membrane was washed three times with TBS-T for 10min and incubated with horseradish
peroxidase (HRP)-conjugated secondary antibody for 1 h at room temperature. After
extensive washing, bands were detected using ECL western blotting detection reagent
(Biosesang). Protein expression levels were determined using the Davinch-K western
image System (Lab plus, Korea).Statistical analysis
All data are presented as mean ± standard deviation (SD) from at least three independent
experiments. The statistical significance was determined using the Student’s t-test for
unpaired samples between two groups. p < 0.05 was considered statistically significant.Results
CBEE inhibited VSMC proliferation
To confirm the effect of CBEE on VSMC anti-proliferation, cells were cultured for 24 h in
complete medium containing 10 % FBS at various concentrations of CBEE (0 ~ 4 μg/ml).
As shown in Fig. 1a, we observed a concentration-dependent decrease in cell viability after
treatment with CBEE. In addition, CBEE exerted a time-dependent decrease in cell viabil-
ity (Fig. 1b). We could not find any Toxicity of CBEE in this study.
Fig. 1 Figure 3. Effects Cordycep species on SMC proliferation. Effects of CBEE on SMC anti-proliferation (a and
b). We evaluated dose and time course responses on SMC anti-proliferation of CBEE. a Dose dependent SMC
anti-proliferation effects of CBEE. Cell counts were conducted after 3 days of culture. b Time dependent SMC
anti-proliferation effects of CBEE. *p < 0.05. **p < 0.01. n = 3 per group. c Effects of three Cordycep species on
SMC proliferation. Serum-starved SMC served as the negative control (NC) and SMCs treated with 10 % fetal
bovine serum (FBS) were the positive control (PC). Data are presented as percent change in negative NC.
Cell counts were conducted after 3 days of culture. **p < 0.01 vs PC. n = 3 per group
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To identify the anti-proliferative effects of other Cordyceps species, VSMC were
cultured for 3 days in complete medium containing 10 % FBS with three Cordyceps
species: CBEE, CMBF, and CPME. A cell proliferation assay showed that CBEE signifi-
cantly inhibited VSMC proliferation (Fig. 1c). However, other Cordyceps species did not
inhibit VSMC proliferation.CBEE inhibited neointima formation
To quantify the effect of CBEE on neointimal hyperplasia, we induced balloon injury in
rats. Histomorphometric analysis using carotid arterry sections was performed. Vehicle
treated group induced abundant neointimal hyperplasia. However, CBEE (4 μg/mL)
treated group exhibited a significant reduction of neointima formation compare with
control (vehicle) group (p = 0.019) (Fig. 2).U0126 inhibit CBEE-induced VSMC anti-proliferation
To better understand the molecular mechanisms involved in the VSMC anti-
proliferative effects of CBEE, we investigated the possible involvement of the MAPK
Fig. 2 Effects of CBEE on neointimal formation. Saline or CBEE was treated for 3 weeks after balloon injury.
Representative photographs of H&E staining (a) and neointima quantification were shown in bar graph (b).
Arrows indicate neointima. *p < 0.05. n = 4 per group
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1/2 activation is involved in CBEE-induced VSMC proliferation, we treated cells with
the MEK/ERK inhibitor U0126 for 1h and then stimulated with CBEE for 72 h. Prolifer-
ation assays were then performed with the CCK-8 assay. The ERK1/2 inhibitor U0126
significantly blocked CBEE-mediated VSMC anti-proliferation in a dose-dependent
manner, as examined by cell counting (Fig. 3).CBEE-activated ERK1/2 phosphorylation
Our previous results prompted us to further investigate whether CBEE activates the
ERK 1/2 signaling pathway. To address this issue, cell lysates were probed for ERK 1/2
phosphorylation and protein levels. Western blot analysis revealed increased ERK 1/2
phosphorylation in VSMCs treated with 4 μg/mL CBEE after 3, 6, and 24 h, with the
maximal increase occurring after 3 h of treatment (Fig. 4).CBEE-activated ERK1/2 phosphorylation is inhibited by U0126
Next, we examined the action of the specific inhibitor U0126 on the ERK 1/2 pathway
activation. Western blot analysis showed that pretreatment with U0126 completely
abrogated CBEE-induced (3- and 6 h) ERK 1/2 phosphorylation (Fig. 5).Fig. 3 Effects of U0126, a specific ERK1/2 inhibitor, on CBEE-induced SMC proliferation. SMC were
treated with the MEK/ERK inhibitor U0126 for 1 h and were then stimulated with CBEE for 72 h.
Proliferation assays were performed with the CCK-8 assay. *p < 0.05. **p < 0.01 vs CBEE-treated cells.
n = 3 per group
Fig. 4 Time course response of ERK activation in SMC treated with CBEE. A western blot was analyzed for
phosphorylated ERK1/2 (p-ERK) and total ERK1/2 (t-ERK1/2). **p < 0.01 vs untreated SMC. n = 3 per group
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Our results clearly demonstrate that CBEE inhibits VSMC proliferation. Notably, CBEE
inhibited VSMC proliferation by modulating the ERK1/2 MAPK signaling pathway. To
the best of our knowledge, this is the first report connecting molecular mechanisms of
CBEE to its anti-proliferative effects on VSMC.
Endothelial injury initiates the pathogenesis of various vascular diseases such as
atherosclerosis [12]. Chronic damage to arterial endothelium leads to lipid
accumulation and adhesion of monocytes and platelets. Various cytokines derived
from these cells promote the migration and proliferation of VSMC, leading to the
later atherosclerotic plaque [1, 13]. Another form of occluded arteries in revascu-
larization is restenosis. Although multiple therapies such as anticoagulants and
antiplatelet agents have been developed, restenosis is still a challenging risk
factor after percutaneous transluminal coronary angioplasty (PTCA) [14]. Throm-
bosis by elastic recoil and vasospasm is the major cause of early restenosis [15].
However, fibrocellular proliferation, which includes VSMC and inflammatory
cells, is the main pathogenic cause of late restenosis [16]. Thus, we explored
natural products as an anti-proliferative drug to treat vascular disease related to
VSMC hyperplasia.
Recent reports indicate that cordycepin inhibits VSMC proliferation [5] and
attenuates neointimal formation by inhibiting reactive oxygen species-mediated
responses [17]. However, the anti-proliferative effects and biological activity of vari-
ous Cordyceps species on VSMC are not fully understood. We found CBEE, which
contained a yellowish colored compound, was reported to have significant anti-Fig. 5 Time course response of ERK activation in SMC treated with CBEE and inhibited with U0126. A western
blot was analyzed for p-ERK and t-ERK1/2. **p < 0.01 vs CBEE only treatment. n = 3 per group
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are limited. One recent report demonstrated that CBEE suppressed the expression
of interleukin-12 and phosphorylation of p38 in lipopolysaccharide-activated macro-
phages without altering cell viability [18]. Interestingly, only CBEE showed inhibi-
tory effect on VSMC in this study. We speculate that other treatment time or
concentration of Cordyceps species extracts (CMBF or CPME) could exhibit inhibi-
tory effect on VSMC. However, major active compounds derived from CBEE and
their anti-proliferative or anti-inflammatory properties compare with CMBF or
CPME should be clarified in further studies.
According previous reports, ERK1/2 has distinct functions in the inhibition of
cell growth [19]. Jung et al. reported that the Ras/ERK1 pathway regulates G1-
phase cell-cycle arrest in cordycepin-induced inhibition of VSMC proliferation [20].
Cordycepin also inhibited DNA synthesis and cell growth. In addition, cordycepin
is associated with proliferative effects via the P38 and JNK MAPK signaling
pathway in several cell lines [21, 22]. Consistent with this report, CBEE activated
phospho-ERK and the ERK inhibitor U0126 inhibited CBEE induced anti-
proliferative effects on VSMC, indicating a significant association with the ERK1/2
MAPK signaling pathway.
Conclusion
In conclusion, CBEE exhibited anti-proliferative properties that affected VSMC through
the ERK1/2 MAPK signaling pathway. Our data may elucidate the inhibitory
mechanism of this natural product, Cordyceps bassiana, and helps us to understand
its protective effects in cardiovascular disease-associated pathophysiology. However,
further studies are necessary to identify the major active components of CBEE.
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